CITIGROUP INC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 66 filers reported holding UROGEN PHARMA LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$5,688
-91.2%
406
-93.5%
0.00%
Q2 2023$64,418
-87.3%
6,224
-88.7%
0.00%
Q1 2023$507,368
+4.7%
54,910
+0.5%
0.00%
Q4 2022$484,435
+16047.8%
54,615
+16400.0%
0.00%
Q3 2022$3,000
-50.0%
331
-55.3%
0.00%
Q2 2022$6,000
-45.5%
741
-39.6%
0.00%
Q1 2022$11,000
-79.2%
1,227
-78.1%
0.00%
Q4 2021$53,000
-8.6%
5,612
+63.0%
0.00%
Q3 2021$58,000
+65.7%
3,443
+49.4%
0.00%
Q2 2021$35,000
+2.9%
2,305
+33.2%
0.00%
Q1 2021$34,000
-57.5%
1,731
-60.9%
0.00%
Q4 2020$80,000
+86.0%
4,426
+96.4%
0.00%
Q3 2020$43,000
-76.5%
2,253
-67.8%
0.00%
Q2 2020$183,000
+51.2%
7,004
+3.6%
0.00%
Q1 2020$121,000
-32.8%
6,759
+25.6%
0.00%
Q4 2019$180,000
+414.3%
5,383
+258.4%
0.00%
Q3 2019$35,000
-83.0%
1,502
-73.8%
0.00%
Q2 2019$206,000
+1772.7%
5,732
+1761.0%
0.00%
Q1 2019$11,0003080.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders